RNA targeting by DNA binding drugs: Structural, conformational and energetic aspects of the binding of quinacrine and DAPI to A-form and HL-form of poly(rC)·poly(rG)
- 31 December 2007
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1770 (12), 1636-1650
- https://doi.org/10.1016/j.bbagen.2007.08.018
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004
- Targeting RNA with Small-Molecule Drugs: Therapeutic Promise and Chemical ChallengesAccounts of Chemical Research, 2001
- Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNAJournal of Molecular Biology, 1998
- Modulation of the rev-RRE interaction by aromatic heterocyclic compoundsBioorganic & Medicinal Chemistry, 1997
- Specific binding of aminoglycoside antibiotics to RNACell Chemical Biology, 1995
- Design and Synthesis of RNA-Specific Groove-Binding Cations: Implications for Antiviral Drug DesignJournal of Medicinal Chemistry, 1994
- The interaction of substituted 2-phenylquinoline intercalates with poly(A) · poly(U): Classical and threading intercalation modes with RNAPeptide Science, 1994
- The search for structure-specific nucleic acid-interactive drugs: Effects of compound structure on RNA versus DNA interaction strengthBiochemistry, 1993
- DAPI (4',6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sitesBiochemistry, 1992
- Gross rearrangements within the 5′-untranslated region of the picornaviral genomesNucleic Acids Research, 1990